Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6614-6621

  Ding, Linna ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CD40 LIGAND; CELLS, CULTURED; GENE EXPRESSION REGULATION; H-2 ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-12; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES;

EID: 0032534567     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
2. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
3. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
4. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
5. Kersh, G. J., and P. M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 222:495.
6. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
7. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Seite, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
8. + T cells by antigenic peptide altered for TCR binding. J. Immunol. 158:4237.
9. Pearson, C. I., W. Van Ewijk, and H. O. McDevitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185:583.
10. Nicholson, L. B., H. Waldner, A. M. Carrizosa, A. Sette, M. Collins, and V. K. Kuchroo. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptide: implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95:364.
11. Sloan-Lancaster, J. A., S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signal: altered phospho-ζ and a Jack of Zap 70 recruitment in APL-induced T cell anergy. Cell 79:913.
12. Madrenas J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. ζ-Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
13. + T cells into Th1 and Th2 subsets. J. Immunol. 159:5802.
14. Kersh, G. J., and P. M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259.
15. Ding, L., P. S. Linsley, L-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectivelyinhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
16. Cella, M., A. Engring, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
17. Freeman, A. S., G. Freeman, J. C. Horowitz, J. Daley, and L. M. Nadler. 1987. B7, a B cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139:3260.
18. Freeman, G. J., A. S. Freeman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:271.
19. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 151:5723.
20. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induced expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
21. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
22. Ding, L., and E. M. Shevach. 1996. Activated B cells express CD28/B7-independent costimulatory activity. J. Immunol. 157:1389.
23. Buhlmann, J. E., T. M. Foy, A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopesian, R. A. Flavell, et al. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645.
24. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
25. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
26. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399.
27. Hardardottir, F., J. L. Baron, and C. A. Janeway. 1995. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92:354.
28. Chen, Y., J.-I. Onobe, V. K. Kuchroo, J. L. Baron, C. A. Janeway, and H. L. Weiner. 1996. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 93:388.
29. Wraith, D. C., D. E. Smilek, D. J. Mitchell, L. Steinman, and H. O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247.
30. Wrath, D. C., B. Bruhn, and P. J. Fairchild. 1992. Cross-reactive antigen recognition by an encephalitogenic T cell receptor: implications for T cell biology and autoimmunity. J. Immunol. 149:3765.
31. Liu, G. Y., and D. C. Wrath. 1995. Affinity for class II MHC determines the extent to which soluble peptide tolerizes autoreactive T cells in naive and primed aduft mice - implications for autoimmunity. Int. Immunol. 7:1255.
32. Ding, L., J. M. Green, C. B. Thompson, and E. M. Shevach. 1995. B7/CD28 dependent and independent induction of CD40 ligand expression. J. Immunol 155:5124.
33. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp Med. 185:817.
34. Scheicher, C., M. Mehlig, H. P. Dtenes, and K. Reske 1995. Uptake of microparticle-absorbed protein antigen by bone marrow dendritic cells results in up-regulation of interleukin-1α and interleukin-12 p40/p35 and triggers prolonged efficient antigen presentation. Eur. J. Immunol. 25:1566.
35. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Bubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
36. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cells stimulatory capacity: T-T help via APC activation, J. Exp. Med. 184:747.
37. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, Jr., and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cells activation, and experimental allergic encephalomyelitis. Science 273:1864.
38. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp 39 and B7 expression and function during antigen-specific immune response. Eur. J. Immunol. 25:596.
39. Jaiswal, A., C. Dubery, S. L. Swain, and M. Croft. 1996. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int. Immunol. 8:275.
40. + T cell differentiation. J. Immunol. 159:5956.
41. Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, and D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
42. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
43. Liu, Y., and C. A. Janeway. 1992. Cells that present both specific ligand and costimulatory activity are most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA 89:3845.
44. Ding, L., and E. M. Shevach. 1994. Activation of CD4 T cells by delivery of the B7 costimulatory signal on bystander antigen presenting cells (trans-costimulation). Eur. J. Immunol. 24:859.
45. Segal, B. M., D. M. Klinman, and E. M. Shevach. 1997. Microbial products induce autoimmune disease by an IL-12 dependent pathway. J. Immunol. 158: 5087.